Immediate Postpartum Glucose Tolerance Testing

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18+
SponsorMemorialCare Health System

About this trial

The objective of this study is to compare the accuracy of a 2hr glucose tolerance test administered during the postpartum hospitalization with the standard of care glucose tolerance testing (administered at 6 weeks postpartum). The primary hypothesis is that the glucose tolerance test administered in the postpartum period will be accurate and will improve compliance with postpartum testing for gestational diabetics.

Eligibility criteria

Qualifiers

Pregnant or recently postpartum (postpartum day 0 or 1)

≥ 18 years of age

Gestational age ≥34 weeks

A1 or A2 gestational diabetes

Disqualifiers

Medical exclusion from completing glucose tolerance testing

Steroid administration within 10 days prior to enrollment

Chronic steroid use

Trial design

Treatments tested in this trial

  • Glucose tolerance test

Treatment groups

300 Participants
are divided into 1 treatment group

Sponsors and collaborators